Christina Marini

NYU Langone Center for Psychedelic Medicine, Department of Psychiatry, New York University Grossman School of Medicine, New York, New York, USA.

2 papers in the library · 4 citations · publishing 0-2023

Papers

Examining the Rationale for Studying Psychedelic-Assisted Psychotherapy for the Treatment of Caregiver Distress.

Psychedelic medicine (New Rochelle, N.Y.) June 1, 2023 Noah D Gold, Samantha K Podrebarac, Lindsay A White et al. 3 citations

Over 50 million Americans serve as unpaid caregivers for chronically ill loved ones, a role that can foster personal growth but also leads to caregiver distress—a mix of physiological, psychological, interpersonal, and spiritual impairments affecting 30-70% of caregivers. Existing treatments do not fully address all these components. Psychedelic-assisted psychotherapy (PAP) has shown promise in clinical trials for conditions overlapping with caregiver distress, such as anxiety, depression, suicidal ideation, and inflammation, while enhancing empathy, connectedness, and reducing existential distress. Although no studies have yet tested PAP for caregiver distress, this narrative review argues it could comprehensively treat all biopsychosocial-spiritual dimensions of the condition, outlining safety, psychedelic selection, and therapeutic structure for future research.

DOI: 10.1089/psymed.2022.0011 Full text MDMA Psilocybin Biopsychosocial–spiritual Caregiver burden +6

Patient Perceptions of Integrating Meditation-based Interventions in Office-based Opioid Treatment with Buprenorphine: A Mixed-methods Survey.

Journal of addiction medicine Babak Tofighi, Christina Marini, Joshua D Lee et al. 1 citation

Among 72 patients prescribed buprenorphine for opioid use disorder in office-based opioid treatment, 90.3% reported practicing at least one category of meditation-based intervention (MBI) on at least a daily (39.6%) or weekly (41.7%) basis. The most common type was spiritual meditation (67.7%), followed by nonmantra meditation (61.3%), mindfulness meditation (54.8%), and mantra meditation (29.0%). Interest in MBI was motivated by improving general health and well-being (73.4%), treatment outcomes (60.9%), and relationships (60.9%). Perceived benefits included reduced anxiety or depression (70.3%), pain (62.5%), substance use (60.9%), cravings (57.8%), and withdrawal symptoms (51.6%). The findings suggest high acceptability for adopting MBI in this population.

DOI: 10.1097/ADM.0000000000001160 Full text